ºÚÁÏÍø

Skip to main content
  • November- Grants and Funding

    Department of Medicine Grants & Funding: November 1 – November 30, 2023

    Division of Hematology Rafal Pawlinski, PhD, and Brandi Reeves, MD, were awarded a one-year $75,000 ºÚÁÏÍø Phase 2 Translational Team Science Award (TTSA) for their project, “evaluating the role of hypoxia inducible factors in endothelial and hematopoietic cells in myeloproliferative neoplasms.” Division of Endocrinology & Metabolism Emily Pfaff, PhD, spoke ab … Read more

  • Buse, Smith Recognized in Global Highly Cited Researchers 2023 List

    Drs. Buse and Smith John Buse, MD, PhD, and Sidney Smith Jr., MD, along with 18 ºÚÁÏÍø and 21 other ºÚÁÏÍø-Chapel Hill researchers have been named in Clarivate’s 2023 list of Highly Cited Researchersâ„¢. These scientific pioneers from around the world are drawn from the publications that rank in the top 1% by citations for field and publication year in the Web of Scien … Read more

  • Faculty and Staff in the News Throughout October

    The clickable links below navigate directly to outside media articles which featured Department of Medicine faculty throughout the month of October.  Evan S. Dellon, MD, MPH, was featured in a New York Times article that depicts a patient’s experience with EoE. Faculty and fellows in the Division of Pulmonary Diseases & Critical Care Medicine attended the NC Thoracic Society … Read more

  • ºÚÁÏÍø Joins Osteoporosis Clinical Trial to Test Specialist-Fracture Liaison Service 

    Donald Caraccio, MD, principal investigator and assistant professor medicine, and Maya Styner, MD, associate professor of medicine, will lead a clinical site for the RESTORE study- REducing future fractureS and improving ouTcOmes of fRagility fracturE.    Bones in patients with osteoporosis often become fragile and have an increased risk for fracture or break. Known as fragility … Read more

  • MacNider Building

    Study Shows Weight Loss Drug Reduces Cardiovascular Risk by 20% in Overweight, Obese Adults

    A new study shows semaglutide 2.4 mg (Wegovy), a weekly injected prescription medication for overweight adults, may prevent major adverse cardiovascular events (MACEs) such as cardiovascular death, non-fatal heart attack or non-fatal stroke. Novo Nordisk released the results of the significant clinical trial called SELECT. The trail studied the effects of Wegovy on people with ca … Read more

  • bonnie-alexander

    Featured Advanced Practice Provider: Bonnie Alexander

    Bonnie Alexander, PA-C, RDN, originally from California, is on our Diabetes Care Team. She began her career as a registered dietitian before finding her love for patient care as a physician assistant. Outside of work Bonnie enjoys doing hot yoga, reading, and traveling. Grain bowls are one of her favorite foods! 

  • Higher Doses of Oral Semaglutide Improves Blood Sugar Control and Weight Loss

    A multicenter, randomized, phase 3b trial, done in collaboration with a ºÚÁÏÍø researcher, found that once-daily oral semaglutide taken at higher doses of 25mg and 50mg improved regulation of blood sugar levels and weight loss compared to the standard 14 mg dose. Diabetes is a progressive disease that affects one’s ability to control blood sugar levels. For many p … Read more

  • john-buse

    Study Shows Metformin Lowers Long COVID Risk

    John Buse, MD, PhD, co-authored a study showing that the common diabetes drug metformin substantially decreased the risk of developing long COVID after infection from SARS-CoV-2. The clinical trial was led by researchers at the University of Minnesota. John Buse, MD, PhD In a new study published in The Lancet Infectious Diseases, University of Minnesota researchers and colleagues … Read more

  • ºÚÁÏÍø Weight Management Team Receives ºÚÁÏÍø Medical Center Quality and Safety Team Award

    Drs. Sarah Ro, Sriram Machineni, Jennifer McCauley The ºÚÁÏÍø Weight Management Team has been awarded a ºÚÁÏÍø Medical Center Quality and Safety Team Award for their project, “Improving Obesity Treatments in Primary Care.” The project was designed to reduce the financial and geographic barriers to obesity treatments across ºÚÁÏÍø primary care clinics. The weight management team embedded t … Read more

  • Klara Klein, Jose Martinez Named to SOM Physician Scientist Training Program

    As part of the Forward Together Strategic Plan, the ºÚÁÏÍø Physician Scientist Training Program (PSTP) supports a small number of clinicians committed to translating research findings to advance the practice of medicine in addition to providing clinical care and teaching. PSTP is a pipeline to recruit, train, and retain promising individuals and provide them with … Read more

  • Dr. Rubin Recognized as Exceptional Mentor to Junior Faculty 

    Dr. Janet Rubin, a researcher renowned for her work on understanding the control of bone remodeling, also spends countless hours mentoring students, fellows and junior faculty. Dr. Rubin has helped advance the careers of dozens of postdoctoral fellows and constructed a program to help transition junior faculty into independent Principal Investigators. An exemplary mentor, Dr. Rub … Read more

  • Cassandra Donahue and Karla Fulghum Receive Research Staff Excellence Awards

    Cassandra Donahue RDN, LDN, CDCES, and Karla Fulghum, RN, IBCLC, were honored with Research Staff Excellence Awards.   Karla is a nurse consultant with the Endocrinology, Diabetes, and Obesity Clinical Research Unit (EnDO CRU) and has been heavily involved in the first inpatient research trial. She has been spending long hours at the hospital and is helping identify and over … Read more